Fibrinolysis in patients with lupus anticoagulant

The fibrinolysis in 6 patients with lupus anticoagulant was studied. The intrinsic fibrinolytic activity by kaolin activated euglobulin with plasminogen free fibrin plate was low level in all patients. Although we could not obtain common results in fibrinolytic factors-plasminogen, α1-AT, α2-M, α2-P...

Full description

Saved in:
Bibliographic Details
Published inBlood & Vessel Vol. 17; no. 6; pp. 585 - 588
Main Authors DEGUCHI, Katsumi, MORI, Yoshitaka, DEGUCHI, Akira, OKUBO, Ituko, TSUDA, Masayuki, NAGANO, Tadashi, MURASHIMA, Seiko, WADA, Hideo, NISHIKAWA, Masakatsu, SHIRAKAWA, Shigeru
Format Journal Article
LanguageEnglish
Published The Japanese Society on Thrombosis and Hemostasis 01.12.1986
Subjects
fibrinolysis
lupus anticoagulant
thrombosis
Online AccessGet full text

Cover

More Information
Summary:The fibrinolysis in 6 patients with lupus anticoagulant was studied. The intrinsic fibrinolytic activity by kaolin activated euglobulin with plasminogen free fibrin plate was low level in all patients. Although we could not obtain common results in fibrinolytic factors-plasminogen, α1-AT, α2-M, α2-PI and Cl-inactivator with immunodiffusion method, and in fibrinolytic activity by euglobulin from plasma with ELT and plasminogen rich fibrin plate. In two patients with Budd-Chiari syndrome, the IgG fraction of plasma through Sephadex G 200 had the inhibitory activity of fibrino (geno) lysis on the fibrin plate method and the immunoelectrophoresis, as well as high lupus anticoagulant activity. Those findings suggest that fibrinolysis plays a role on formation of thrombus in patient with lupus anticoagulant.
ISSN:0386-9717
1884-2372
DOI:10.2491/jjsth1970.17.585